PDIA4 and endothelial dysfunction: These data suggest that PDIA-4 may be a potentially novel and previously unrecognized target to modulate autophagy, endothelial function and EndMT in endothelial cells to limit impaired autophagy, endothelial dysfunction and/or EndMT-associated diseases.